FMC Aguadilla Dialysis Center is a medicare approved dialysis facility center in Aguadilla, Puerto Rico and it has 23 dialysis stations. It is located in Aguadilla county at Carr 459 Km 0.7 Bo Camaseyes, Aguadilla, PR, 00603. You can reach out to the office of FMC Aguadilla Dialysis Center at (787) 882-1212. This dialysis clinic is managed and/or owned by Fresenius Medical Care. FMC Aguadilla Dialysis Center has the following ownership type - Profit. It was first certified by medicare in October, 1990. The medicare id for this facility is 402513 and it accepts patients under medicare ESRD program.
Name | FMC Aguadilla Dialysis Center |
---|---|
Location | Carr 459 Km 0.7 Bo Camaseyes, Aguadilla, Puerto Rico |
No. of Dialysis Stations | 23 |
Medicare ID | 402513 |
Managed By | Fresenius Medical Care |
Ownership Type | Profit |
Late Shifts | Yes |
Carr 459 Km 0.7 Bo Camaseyes, Aguadilla, Puerto Rico, 00603 | |
(787) 882-1212 | |
Not Available |
News Archive
As a unique scientific panel it brings together top scientists as well as promising young researchers from different disciplines in a personal and selected ambience.
A nine-year joint research project conducted by VIB, KU Leuven and VUB has led to a crucial breakthrough in cancer research.
The latest developments in health policy from California, the District of Columbia, Georgia, Maryland, Minnesota, Oregon and Texas.
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced it led a $17.4 million Series B financing round for Quinnova Pharmaceuticals, Inc., with participation from existing investors Thomas, McNerney & Partners and H.I.G. BioVentures.
In the most comprehensive analysis yet of ketogenic (keto) diets, a review in Frontiers in Nutrition finds keto diets place pregnant women and kidney disease patients at risk of adverse health effects.
› Verified 2 days ago
NPI Number | 1447359864 |
Organization Name | Bma Aguadilla |
Doing Business As | Bio-medical Applications Of Aguadilla, Inc. |
Address | Road #459, Km. 0.7 Aguadilla, Puerto Rico, 00605 |
Phone Number | (787) 882-1212 |
News Archive
As a unique scientific panel it brings together top scientists as well as promising young researchers from different disciplines in a personal and selected ambience.
A nine-year joint research project conducted by VIB, KU Leuven and VUB has led to a crucial breakthrough in cancer research.
The latest developments in health policy from California, the District of Columbia, Georgia, Maryland, Minnesota, Oregon and Texas.
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced it led a $17.4 million Series B financing round for Quinnova Pharmaceuticals, Inc., with participation from existing investors Thomas, McNerney & Partners and H.I.G. BioVentures.
In the most comprehensive analysis yet of ketogenic (keto) diets, a review in Frontiers in Nutrition finds keto diets place pregnant women and kidney disease patients at risk of adverse health effects.
› Verified 2 days ago
Dialysis patients with Hemoglobin data | 56 |
News Archive
As a unique scientific panel it brings together top scientists as well as promising young researchers from different disciplines in a personal and selected ambience.
A nine-year joint research project conducted by VIB, KU Leuven and VUB has led to a crucial breakthrough in cancer research.
The latest developments in health policy from California, the District of Columbia, Georgia, Maryland, Minnesota, Oregon and Texas.
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced it led a $17.4 million Series B financing round for Quinnova Pharmaceuticals, Inc., with participation from existing investors Thomas, McNerney & Partners and H.I.G. BioVentures.
In the most comprehensive analysis yet of ketogenic (keto) diets, a review in Frontiers in Nutrition finds keto diets place pregnant women and kidney disease patients at risk of adverse health effects.
› Verified 2 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
Adult patients getting regular hemodialysis at the center | 92 |
Adult patient months included in Kt/V greater than or equal to 1.2 | 808 |
Percentage of adult patients getting regular hemodialysis at the center | |
Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
As a unique scientific panel it brings together top scientists as well as promising young researchers from different disciplines in a personal and selected ambience.
A nine-year joint research project conducted by VIB, KU Leuven and VUB has led to a crucial breakthrough in cancer research.
The latest developments in health policy from California, the District of Columbia, Georgia, Maryland, Minnesota, Oregon and Texas.
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced it led a $17.4 million Series B financing round for Quinnova Pharmaceuticals, Inc., with participation from existing investors Thomas, McNerney & Partners and H.I.G. BioVentures.
In the most comprehensive analysis yet of ketogenic (keto) diets, a review in Frontiers in Nutrition finds keto diets place pregnant women and kidney disease patients at risk of adverse health effects.
› Verified 2 days ago
Adult patients getting regular peritoneal dialysis at the center | 34 |
Adult patient months included in Kt/V greater than or equal to 1.7 | 303 |
Percentage of adult patients getting regular peritoneal dialysis at the center | |
Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
As a unique scientific panel it brings together top scientists as well as promising young researchers from different disciplines in a personal and selected ambience.
A nine-year joint research project conducted by VIB, KU Leuven and VUB has led to a crucial breakthrough in cancer research.
The latest developments in health policy from California, the District of Columbia, Georgia, Maryland, Minnesota, Oregon and Texas.
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced it led a $17.4 million Series B financing round for Quinnova Pharmaceuticals, Inc., with participation from existing investors Thomas, McNerney & Partners and H.I.G. BioVentures.
In the most comprehensive analysis yet of ketogenic (keto) diets, a review in Frontiers in Nutrition finds keto diets place pregnant women and kidney disease patients at risk of adverse health effects.
› Verified 2 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at FMC Aguadilla Dialysis Center with elevated calcium levels.
Patients with hypercalcemia | 146 |
Hypercalcemia patient months | 1333 |
Hypercalcemia patients with serumcalcium greater than 10.2 mg | |
Patients with Serumphosphor | 156 |
Patients with Serumphosphor less than 3.5 mg/dL | |
Patients with Serumphosphor from 3.5 to 4.5 mg/dL | |
Patients with Serumphosphor from 4.6 to 5.5 mg/dL | |
Patients with Serumphosphor from 5.6 to 7 mg/dL | |
Patients with Serumphosphor greater than 7 mg/dL |
News Archive
As a unique scientific panel it brings together top scientists as well as promising young researchers from different disciplines in a personal and selected ambience.
A nine-year joint research project conducted by VIB, KU Leuven and VUB has led to a crucial breakthrough in cancer research.
The latest developments in health policy from California, the District of Columbia, Georgia, Maryland, Minnesota, Oregon and Texas.
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced it led a $17.4 million Series B financing round for Quinnova Pharmaceuticals, Inc., with participation from existing investors Thomas, McNerney & Partners and H.I.G. BioVentures.
In the most comprehensive analysis yet of ketogenic (keto) diets, a review in Frontiers in Nutrition finds keto diets place pregnant women and kidney disease patients at risk of adverse health effects.
› Verified 2 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
Patients included in arterial venous fistula and catheter summaries | 86 |
Patient months included in arterial venous fistula and catheter summaries | 651 |
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | |
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer |
News Archive
As a unique scientific panel it brings together top scientists as well as promising young researchers from different disciplines in a personal and selected ambience.
A nine-year joint research project conducted by VIB, KU Leuven and VUB has led to a crucial breakthrough in cancer research.
The latest developments in health policy from California, the District of Columbia, Georgia, Maryland, Minnesota, Oregon and Texas.
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced it led a $17.4 million Series B financing round for Quinnova Pharmaceuticals, Inc., with participation from existing investors Thomas, McNerney & Partners and H.I.G. BioVentures.
In the most comprehensive analysis yet of ketogenic (keto) diets, a review in Frontiers in Nutrition finds keto diets place pregnant women and kidney disease patients at risk of adverse health effects.
› Verified 2 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
Patients in facility's Hospitalization Summary | |
Hospitalization Rate in facility | (Not Available) |
Hospitalization Rate: Upper Confidence Limit | |
Hospitalization Rate: Lower Confidence Limit |
News Archive
As a unique scientific panel it brings together top scientists as well as promising young researchers from different disciplines in a personal and selected ambience.
A nine-year joint research project conducted by VIB, KU Leuven and VUB has led to a crucial breakthrough in cancer research.
The latest developments in health policy from California, the District of Columbia, Georgia, Maryland, Minnesota, Oregon and Texas.
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced it led a $17.4 million Series B financing round for Quinnova Pharmaceuticals, Inc., with participation from existing investors Thomas, McNerney & Partners and H.I.G. BioVentures.
In the most comprehensive analysis yet of ketogenic (keto) diets, a review in Frontiers in Nutrition finds keto diets place pregnant women and kidney disease patients at risk of adverse health effects.
› Verified 2 days ago